The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II

Journal of Crohn's and Colitis

Volumn 9, Issue 4, 2015, Pages 342-348

  Rossen, Noortje G ^a   Fuentes, Susana ^b   Boonstra, Kirsten ^a   D'Haens, Geert R ^a   Heilig, Hans G ^b   Zoetendal, Erwin G ^b   de Vos, Willem M ^b,c   Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Inflammatory bowel disease; Intestinal microbiota; Primary sclerosing cholangitis

Indexed keywords

RNA 16S; BACTERIAL RNA;

ADULT; AGED; ARTICLE; ASCENDING COLON; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLOSTRIDIALES; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; INTESTINE MUCOSA; MALE; MICROBIAL DIVERSITY; MICROFLORA; NONHUMAN; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SPECIES COMPOSITION; SPECIES RICHNESS; TERMINAL ILEUM; ULCERATIVE COLITIS; BIOPSY; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONOSCOPY; COMPLICATION; CROSS-SECTIONAL STUDY; GENETICS; GRAM POSITIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; BIOPSY; CHOLANGITIS, SCLEROSING; CLOSTRIDIALES; COLITIS, ULCERATIVE; COLONOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTESTINAL MUCOSA; MALE; MICROBIOTA; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, BACTERIAL; YOUNG ADULT;

EID: 84937426489     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jju023     Document Type: Article

References (31)

1. Fevery J, Henckaerts L, Oirbeek R van, et al. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term singlecentre study. Liver Int 2012;32:214-22
2. Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045-55
3. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181-8
4. O'Toole A, Alakkari A, Keegan D, et al. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol 2012;10:439-41
5. Boonstra K, Erpecum KJ van, Nieuwkerk KMJ van, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2270-6
6. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621
7. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-9
8. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54.e1
9. Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010;105:2420-8
10. Rajilic-Stojanovic M, Shanahan F, Guarner F, et al. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 2013;19:481-8
11. Lichtman SN, Keku J, Clark RL, et al. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 1991:414-23
12. Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 2013;60:940-47
13. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8
14. Zoetendal EG, Wright A Von, Vilpponen-Salmela T, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002;68:3401-7
15. EASL. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-67
16. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9
17. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-9
18. Rajilic-Stojanovic M, Heilig HGHJ, Molenaar D, et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009;11:1736-51
19. Rajilic-Stojanovic M, Heilig HGHJ, Tims S, et al. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 2012;15:1146-59
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodological 2012;57:289-300
21. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013;339:548-54
22. Nood E van, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15
23. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6
24. Lahti L, Salojärvi J, Salonen A, et al. Tipping elements in the human intestinal ecosystem. Nat Commun 2014;5:1-10
25. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607
26. Batta AK, Salen G, Arora R, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989 Oct;10:414-9
27. Sinakos E, Marschall H, V. Kowdley K, et al. Bile acid changes after highdose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression. Hepatology 2011;52:197-203
28. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013;505:559-63
29. Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013;62:531-9
30. Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 2014;60:824-31
31. Kevans D, Tyler AD, Silverberg MS, et al. Characterization of the intestinal microbiome in ulcerative colitis patients with and without primary sclerosing cholangitis. In: Abstracts accepted to 2014 CCDWCASL Winter Meeting, A145. An abstract of this work was presented at Digestive Disease Week 2014, Chicago, USA